CATARACTS IN CHILDREN ON LONG-TERM CORTICOSTEROID THERAPY.
D000293:Adolescent; D000305:Adrenal Cortex Hormones; D002386:Cataract; D002648:Child; D002738:Chloroquine; D003520:Cyclophosphamide; D004358:Drug Therapy; D005477:Fluprednisolone; D006801:Humans; D008180:Lupus Erythematosus, Systemic; D015122:Mercaptopurine; D009404:Nephrotic Syndrome; D010248:Paramethasone; D011241:Prednisone / Q000627:therapeutic use*; D013444:Sulfisoxazole; D014116:Toxicology; D014221:Triamcinolone
D000305:Adrenal Cortex Hormones; D014221:Triamcinolone; D013444:Sulfisoxazole; D002738:Chloroquine; D003520:Cyclophosphamide; D005477:Fluprednisolone; D015122:Mercaptopurine; D011241:Prednisone; D010248:Paramethasone
ADOLESCENCE; ADRENAL CORTEX HORMONES; CATARACT; CHILD; CHLOROQUINE; CYCLOPHOSPHAMIDE; DRUG THERAPY; FLUPREDNISOLONE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MERCAPTOPURINE; NEPHROTIC SYNDROME; PARAMETHASONE; PREDNISONE, THERAPEUTIC; SULFISOXAZOLE; TOXICOLOGIC REPORT; TRIAMCINOLONE